newsfilter
← Latest News
PR Newswire·

MediPharm Labs Settles an Outstanding Claim for $9M

TORONTO, Oct. 2, 2023 /CNW/ - MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a company specialized in precision-based cannabinoids, is